Thermo Fisher Scientific’s microbiology business acquired by Astorg
Astorg agreed to acquire Thermo Fisher Scientific’s microbiology business, a life sciences brand, on Apr 27, 2026.
Preliminary: The announcement date is not yet independently verified.
Transaction summary
- Target
- Thermo Fisher Scientific’s microbiology business
- Acquirer
- Astorg
- Seller
- Thermo Fisher Scientific
- Announced
- 2026-04-27(unverified)
- Geography
- -
- Type
- Acquisition
- Deal type
- Control
- Stake acquired
- -
- First added
- 2026-07-13
- Latest update
- 2026-10-29
Value and multiples
100% enterprise value
USD 1.1B
100% enterprise value | USD
Basis: Public source
Reported price is assumed to be 100% EV unless stated otherwise. Partial-stake estimates are qualified in the basis notes.
EV / revenue
-
Period not stated
Basis: FundComb estimate
EV / EBITDA
-
EBITDA basis not stated
Basis: FundComb estimate
Amounts paid and other reported values
Original reported amounts and bases; a stake payment is distinct from the estimated whole-company valuation.
Consideration: USD 1.1B
Linked news headline reports Astorg is to acquire Thermo Fisher Scientific’s microbiology business for US$1.075bn.
Basis
- Reported consideration: USD 1.1bn.
Source summary
Luxembourg: Astorg to acquire Thermo Fisher Scientific’s microbiology business for US$1.075bn - Investors in Healthcare
ConfirmedContinue your research
Related transaction comps
Bio-Techne acquired by Merck KGaA, Darmstadt, Germany
2026-06-25 · Confirmed
View transaction → Life SciencesElement Materials Technology’s Life Sciences Testing Services Business in North America acquired by Eurofins
2026-07-20 · Confirmed
View transaction → Life SciencesClarivate Life Sciences & Healthcare segment acquired by Altaris LLC
2026-07-06 · Confirmed
View transaction → Life SciencesClario Holdings, Inc. acquired by Thermo Fisher Scientific
2025-10-29 · Confirmed
View transaction →